Stock Market Graph

Search Results

Search

Journey to $1 Million - March 18th, 2021

I do live trading on my Twitter and would like to post the real option trades that I am doing, and what my current watchlist is. Follow along on my journey to $1 million.

1-on-1 Private Coaching via Zoom is now available. Whether it is portfolio building and review, formulating a personalized options strategy, or the basics of how to trade - I'll make your portfolio relevant. Email me here or DM me via social media.

YouTube Video Commentary: Here

Yesterday turned out very well. The Fed meeting is finished and for the most part nothing is new. 10 year bond yields peaked at 1.689% but dropped back down to 1.641%. The tech sector was very choppy, but everything was mostly finished green.


My portfolio finished up almost $18k, or 2.77%.

Markets:

  • SPY: +0.34%

  • QQQ: +0.40%

  • DIA: 0.58%

Yesterday's Picks:

  • $VWAGY: +29.25%

  • $FLGT: +12.27%

  • $SOXL: +5.3%

Adding to the Watchlist:

$TTWO: Take-Two Interactive Software, Inc. is an American video game holding company based in New York City and founded by Ryan Brant in September 1993. The company owns two major publishing labels, Rockstar Games and 2K, which operate internal game development studios. $TTWO delivered a 69% return in 2020, reaching a new high of around $200 at the start of the new year. Investors are hopeful that the elevated player engagement trends during the pandemic will carry into 2021.


After coming off of the high of $214 and to forward of a price to earnings, now $TTWO is trading below the 180MA at $169. P/E is currently around 27. The company owning some of the biggest and most impactful triple A titles of the past decade, this might be to hard to pass up.

  • Target Price: $220

  • Entry: <$168

  • Risk: 4

  • Timeframe: 3-5 months


$SRPT: Sarepta Therapeutics, Inc. is a medical research and drug development company is the leader in precision genetic medicine for rare diseases. Sarepta will soon release additional data from the Phase 2 trial of the company's next-generation exon skipper SRP-5051. The treatment uses Sarepta’s peptide phosphorodiamidate morpholino oligomer (PPMO) technology. "With the stock trading near floor value of SRPT's exon-skipper base business,” Schwartz summed up, “Now could be an opportune time to get involved ahead of PPMO data expected in 2Q21.”


Eventhough I will give this a risk of 5, I think that since the stock has dropped 50% it could double with good data results on its new treatment. I'm only interested in limiting downside here, so a simple vertical spread would be best.

  • Target Price: $170

  • Entry: <$80

  • Risk: 5

  • Timeframe: 5-8 months


$PLUG: Plug Power Inc. is an American company engaged in the development of hydrogen fuel cell systems that replace conventional batteries in equipment and vehicles powered by electricity.


$PLUG stock sold off after they announced accounting errors in results for 2018, 2019 and the first three quarters of 2020, but Chief Executive Officer Andy Marsh noted that the mistakes didn’t affect the underlying business. This looks very bad more than anything, and in my opinion there is probably more selling off to come in the short term. Once the price gets closer towards the 180MA, I will start buying. There are still to many upsides to the company, and such cheap prices are hard to ignore.

  • Target Price: $75

  • Entry: <$30

  • Risk: 4

  • Timeframe: 4-6 months

Note: Risk (1 out of 5) is my opinion of how risky the stock and these plays are; 1 being the lowest and 5 is the highest.

Follow me on Social Media!

Twitter

Youtube

IG

Webull -2 Free Stocks

Disclaimer: The comments opinions and analysis expressed herein are for informational and educational purpose only and should not be considered as individual advice or recommendations. Prostockadvice.com is not responsible or liable in any way for opinions expressed here. This is not meant to be financial advice as we are not a licensed financial advisor.


626 views0 comments